Purpose Our aim was to retrospectively analyze the location of confluent hepatic fibrosis in relation to the portal and hepatic venous anatomy using multidetector computed tomography (CT) and to clarify the influence of the hepatic venous drainage on confluent fibrosis. Materials and methods The study population consisted of 879 patients diagnosed with cirrhosis: 539 men and 340 women (65.9 ± 10.6 years) and 633 with Child-Pugh class A, 161 with class B, and 85 with class C. The cause of cirrhosis was hepatitis C (n = 528) and hepatitis B (n = 122) virus infection, alcoholism (n = 114), and others (n = 115). The confluent fibrosis was diagnosed using CT images according to previous reports and statistically analyzed (p \ 0.05). Results Thirty-five confluent fibrosis lesions in 30 patients (3.4 %) were identified. The predictive factors were alcoholic cirrhosis [odds ratio (OR), 7.25; p \ 0.0001], ChildPugh class C (OR, 6.95; p \ 0.0001), and Child-Pugh class B (OR, 2.91; p \ 0.0023). Confluent fibrosis was most frequently seen in the middle hepatic venous drainage area (n = 21) or at the boundary between the medial and anterior segments (n = 17), and each distribution of the location of confluent fibrosis was significantly unequal (p \ 0.0001).
Introduction
Liver fibrosis, a common feature of almost all causes of chronic liver disease, refers to the excess deposition of collagen, proteoglycans, and other macromolecules in the extracellular matrix in response to repetitive liver injury from various causes [1] . Liver fibrosis is considered to be irreversible but is regarded as a dynamic process with potential for regression [2] . During its progression, accumulation of proteins in the extracellular matrix promotes formation of scars that bridge together across adjacent portal triads and central veins, and ultimately, hepatic fibrosis can be demonstrated on computed tomography (CT) or magnetic resonance (MR) imaging as fibrotic septa and bridges in patients with end-stage liver disease [2, 3] .
Confluent hepatic fibrosis is considered to be the most extreme stage of fibrosis and is occasionally encountered in patients with end-stage cirrhosis. It is demonstrated as broad fibrotic scars, and imaging findings have been summarized as a focal, often wedge-shaped, mass with either overlying capsule retraction or focal flattening of the capsule, most often involving the anterior and medial segment and less frequently the posterior segment [4, 5] . Ohtomo et al. [4] speculated that the mechanism of this change might be related to impaired portal microcirculation, although the intrahepatic portal venous system was grossly patent. After the original reports, several cases showing similar locations of confluent fibrosis were described [6] [7] [8] [9] [10] . However, it has not been clarified why the fibrosis of diffuse liver disease, a basically diffuse process, appears preferentially in these particular segments as confluent fibrosis.
It is widely recognized that a decreased or reversed flow of the portal blood supply can be seen when the hepatic venous flow is obstructed [11, 12] . As a result, parenchymal changes similar to those evoked by portal venous flow blockage can be expected, resulting in marked fibrosis in the area with hepatic venous flow disturbance. Furthermore, in cirrhosis, hepatic venous flow disturbance due to compression and deformity caused by regenerative nodules and fibrosis is one of the most important causes of portal hypertension [13] . In addition, Ozaki et al. [14] previously reported that selective atrophy of middle hepatic venous (MHV) drainage area commonly occurs in hepatitis C-related liver cirrhosis (mostly macronodular cirrhosis). Based on these facts and observations, we speculated that disturbed hepatic venous drainage might be related to the development of confluent fibrosis.
In this study, we retrospectively analyzed the location of confluent fibrosis in relation to the portal venous supply and hepatic venous drainage using multidetector computed tomography (CT) to clarify the influence of hepatic venous drainage on confluent fibrosis.
Materials and methods
Institutional approval was obtained for this retrospective study, and informed consent to use the medical records and materials for this study was obtained from all patients.
Patients
Between October 2002 and August 2009, we evaluated 1,327 consecutive patients with cirrhosis at our institution who underwent upper abdominal dynamic CT to evaluate the stage of their chronic liver injury and to detect any associated hepatocellular carcinoma. There were 854 men and 473 women, with a mean age of 66.2 ± 10.7 (range, 7-90) years. Four hundred and forty-eight patients were excluded because of difficulty in accurately evaluating the morphology of the liver or the locations based on the portal or hepatic vein due to a history of transcatheter arterial chemoembolization and/or radiofrequency ablation (n = 230), severe deformation or hepatomegaly due to advanced tumor (n = 113), history of hepatectomy (n = 69), interruption of the scan because of the development of a contrast-material-related allergy (n = 20), history of living-donor liver transplantation (n = 9), or history of transjugular intrahepatic portosystemic shunt (n = 7). The final study population consisted of 879 patients, 539 men and 340 women with a mean age of 65.9 ± 10.6 (range, 7-89) years, and 633 patients with Child-Pugh class A cirrhosis, 161 with Child-Pugh class B, and 85 with Child-Pugh class C. The cause of cirrhosis was hepatitis C virus infection (n = 528), hepatitis B virus infection (n = 122), alcoholism (n = 114), unknown etiology (n = 36), primary biliary cirrhosis (PBC) (n = 31), nonalcoholic steatohepatitis (NASH) (n = 24), autoimmune hepatitis (AIH) (n = 15), hepatitis C and B virus infection (n = 3), Budd-Chiari syndrome (n = 3), hepatitis C virus infection and alcoholism (n = 2), or Wilson's disease (n = 1). More details are noted in Table 1 . Diagnosis of cirrhosis was based on histology in 626 patients: percutaneous liver biopsy (n = 591), hepatectomy for hepatocellular carcinoma (n = 32), and liver transplantation (n = 3). Histological data were adjunctively referred to in patients who underwent hepatectomy or liver transplantation if confluent fibrosis was detected. In the remaining 253 patients [hepatitis C virus infection (n = 187), hepatitis B virus infection (n = 51), alcoholism (n = 12), and Budd-Chiari syndrome (n = 3)], a clinical diagnosis of cirrhosis was based on a combination of imaging findings (ultrasound, CT, and/or MR imaging) [15] [16] [17] , upper gastrointestinal endoscopic findings (esophageal and/or gastric varices), abnormal laboratory data (prolonged prothrombin time, decreased platelet count, abnormal serum albumin and cholesterol levels, increased total bilirubin and c-globulin levels, specific antinuclear antibody, and so on), and clinical presentation (cutaneous spider angiomas, abdominal subcutaneous portosystemic shunts, ascites, hepatic encephalopathy, and so on) or clinical history (drinking history, other disease). Most patients were not candidates for liver biopsy because of advanced end-stage cirrhosis or refusal of biopsy.
Imaging techniques
Abdominal dynamic CT images were obtained with a LightSpeed Ultra 16 (GE Medical Systems, USA) (n = 723), or a LightSpeed VCT 64 (GE Medical Systems) (n = 156) that was introduced in March 2008. Images obtained with the LightSpeed Ultra 16 were acquired through the liver in a craniocaudal direction, with a 1.5 9 16-beam collimation. Other CT parameters were as follows: 300-350 mAs; 120 kVp; detector collimation, 2.5 mm; table speed, 14 mm per rotation; gantry rotation time, 0.5 s; reconstruction section thickness of 2.5 mm and a reconstruction interval of 2.5 mm. Before each scan, patients were instructed to breathe in and hold during scanning. Following precontrast CT, a dynamic contrast study was performed 30 s (arterial phase), 60 s (portal phase), and 120 s (equilibrium phase) after completion of an intravenous injection of 600 mgI/kg of nonionic contrast material (Iomeron 350, Eisai, Tokyo, Japan) at a rate of 3-4 ml/s. Using these acquisition parameters, the approximate mean volume CT dose index was 18.2 mGy, and the dose-length product was 550.1 mGy/cm per scan. Images obtained with a LightSpeed VCT 64 were acquired through the liver in a craniocaudal direction, with a 0.625 9 64-beam collimation. Other CT parameters were as follows: auto mA (GE Healthcare; 10-700 mA, noise index 8.0); the remainder was the same as noted above. Following precontrast CT, a dynamic contrast study was performed using the Smart Prep option (automated software with scan triggering; GE Medical Systems), and 600 mgI/kg of nonionic contrast material (Iomeron 350) was administered for 30 s. Arterial-phase scanning was initiated just after a 200-Hounsfield unit (HU) enhancement threshold was achieved in the aorta at the level of the celiac artery. The portal-and equilibrium-phase scanning were performed at 35s and 115-s delays, respectively, from the time of initiation of the arterial-phase scanning. Using these acquisition parameters, the approximate mean volume CT dose index was 18.7 mGy, and the dose-length product was 570.3 mGy/cm per scan.
Definition of confluent hepatic fibrosis
The presence of confluent fibrosis was evaluated based on the original report of Ohtomo et al. [4] . Imaging findings are as follows: wedge-shaped, peripheral, and band-shaped lesions remote from the central portion of the liver, or segmental involvement. On precontrast CT, it usually shows hypoattenuation relative to the surrounding liver parenchyma. The lesion might be isoattenuating when the density of surrounding liver parenchyma is lower than usual. On the arterial phase, it may show a variety of enhancement patterns on CT and MR imaging [6, 17] . A variable degree of delayed enhancement is commonly seen on the equilibrium phase [6, 18] . The lesions show varying degrees of parenchymal shrinkage of the involved area and capsule retraction. No calcification or dilatation of intrahepatic biliary ducts is seen. The portal trunk and major hepatic vein, including its major branches, were confirmed to be patent to exclude morphological changes due to thrombus or tumor invasion. CT images in all 879 patients were interpreted, and the presence of confluent fibrosis was identified retrospectively by three experienced abdominal radiologists (two with [10 and the other with [30 years of experience each in liver imaging). All images were analyzed subjectively and independently by these three radiologists.
Definition of hepatic segments
In cases with confluent fibrosis, its location was categorized according to the hepatic segmentation defined by the Couinaud system [19] : lateral, medial, anterior, and posterior segments, and caudate lobe. The portal vein was traced from the main portal trunk to the peripheral branch using a viewer (EV Insite Version 2.10.7.91, PSP Corporation, Tokyo, Japan) during the portal phase of axial CT, and the location was categorized based on the branches supplying the lesion. The location of confluent fibrosis was also categorized according to the hepatic venous branches. They were classified as left, middle, and right hepatic venous (LHV, MHV, and RHV) drainage areas [20, 21] . The hepatic veins were traced from the point of convergence with the inferior vena cava, or the point of convergence of the MHV and LHV up to the hepatic surface during the portal-phase or equilibrium phase of axial CT using the viewer, and the drainage branches to the lesion were identified. The branch of the major hepatic vein that was reached was defined as each hepatic venous drainage area. The vessels and their location were identified by the same three radiologists in consensus. Representative cases of confluent fibrosis are shown in Figs. 1 and 2 .
Statistical analysis
used to identify significant factors of confluent hepatic fibrosis. Significant variables in the univariate analyses were included. The cause was categorized as alcoholism or others for the same reason mentioned above. The Cochran-Armitage trend test was used to assess frequency of confluent fibrosis according to Child-Pugh classification. The chisquare test for goodness of fit with Yates' continuity correction was used to access location distribution of the confluent fibrosis based on the portal blood supply or hepatic venous drainage. Cases with lesions infrequently observed were categorized as others, if needed. All analyses were performed with statistical software (Dr. SPSS II for Windows, version 11.0.1J; SPSS, Chicago, IL, USA) or Excel Statistics 2010 (Social Survey Research Information, Tokyo, Japan), and p \ 0.05 was considered statistically significant.
Results
Thirty-five focal confluent fibrosis lesions in 30 patients (3.4 %) were identified. Twenty-five patients (83.3 %) had Fig. 1 A 52-year-old man with alcoholic cirrhosis classified as Child-Pugh class B. a Precontrast computed tomography (CT) image shows a wedge-shaped, lowattenuation area accompanied by capsule retraction and volume loss, which was defined as confluent fibrosis (arrowhead). b Arterial-phase CT image shows less marked enhancement of the lesion than that of adjacent hepatic parenchyma (arrowhead). c Portal-phase CT image shows trapped branches of P8 and P4 within confluent fibrosis (arrowhead). The lesion was located at the boundary between anterior and medial segments. d Equilibrium-phase CT image shows trapped middle hepatic venous (MHV) branches within confluent fibrosis (arrowhead). The lesion was located in the MHV drainage area a single lesion, five (16.7 %) had two lesions, and there were none with three or more lesions. In three patients, lesions were confirmed histologically by liver transplantation and in one by partial hepatectomy for hepatocellular carcinoma at a different location. They were 24 men and six women (Fisher's exact test, p = 0.036), mean age 62.6 ± 10.3 (range, 44-84) years (Mann-Whitney U test, p = 0.039). Cause of confluent fibrosis was alcoholism (n = 17/114) (14.9 %), AIH (n = 1/15) (6.7 %), PBC (n = 1/31) (3.2 %), unknown etiology (n = 1/36) (2.8 %), or hepatitis C virus infection (n = 10/528) (1.9 %). Cirrhosis classification was Child-Pugh class A (n = 11/633) (1.7 %), class B (n = 9/161) (5.6 %), and class C (n = 10/ 85) ( Table 2 ). Confluent fibrosis frequency was significantly correlated with cirrhosis progression (P \ 0.0001). Lesion location based on portal venous blood supply according to Couinaud's segmental system was as follows: medial and anterior segments, precisely expressed as the boundary between the medial and anterior segments based on CT images (n = 17) (Figs. 1, 2) ; anterior segment (n = 7); anterior and posterior segments (n = 3); lateral segment (n = 3); medial, anterior, and posterior segments (n = 2); medial segment (n = 1); posterior segment (n = 1); and lateral, medial, and anterior segments (n = 1). No lesion involved the caudate lobe ( Table 3 ). The goodness-of-fit test showed unequal distribution of confluent fibrosis location [v 5 2 = 28.26, p \ 0.0001; the last three locations (n = 1) were categorized as others].
The location based on hepatic venous drainage was as follows: MHV drainage area (n = 21) (Figs. 1, 2) , RHV drainage area (n = 8), LHV drainage area (n = 3), and MHV and RHV drainage areas (n = 3) ( Table 4 ). The goodness-of-fit test showed unequal distribution of confluent fibrosis location (v 3 2 = 24.77, p \ 0.0001). 
Discussion
In this study, we assessed confluent hepatic fibrosis in patients with liver cirrhosis in relation to the portal and hepatic venous anatomy. The results showed confluent fibrosis in 3.4 % of patients with cirrhosis. Lesions were most commonly seen in patients with advanced and/or alcoholic cirrhosis and in the MHV drainage area in terms of hepatic venous drainage or at the boundary between medial and anterior segments in terms of portal venous supply. In general, the MHV receives blood mainly from the medial segment and ventral portion of the anterior segment [22] , and the most common site of confluent fibrosis was confirmed to be within the MHV drainage area.
The prevalence of confluent fibrosis in our study (3.4 %, 30 of 879 patients) is lower than that in Ohtomo's study [4] and is thought to be due to the difference in cirrhosis stage. Two-thirds of patients were classified as Child-Pugh class A in our study, and this study population consisted largely of less advanced cirrhosis compared with patients with relatively advanced cirrhosis who underwent liver transplantation in Ohtomo's study.
The developmental mechanism of confluent fibrosis is speculated to be related to impaired portal microcirculation [4, 22] . This speculation is based on the fact that decreased or absent portal blood supply was detected on CT during arterial portography [23] and that reduced portal flow results in loss of volume of hepatocytes with increased fibrosis and segmental liver atrophy [24] . However, in our study, confluent fibrosis was located most commonly at the boundary between the anterior and medial segments. Simultaneous reduction of portal blood supply in both the medial and ventral portions of the anterior segment may be difficult to explain based on a hypothetical disproportion of the portal blood supply. Other factors, such as so-called Stepwise multivariate logistic regression analysis included variables that were significant in the univariate analyses. The significant predictive factors of confluent fibrosis were alcoholic cirrhosis, Child-Pugh class C, and Child-Pugh class B Table 3 Location of confluent hepatic fibrosis in terms of portal venous supply
Location

Number of lesions
Medial and anterior segments (boundary between the medial and anterior segments)
17
Anterior segment 7
Anterior and posterior segments 3
Lateral segment 3
Medial, anterior, and posterior segments 2
Medial segment 1
Posterior segment 1
Lateral, medial, and anterior segments 1
Total 35
The goodness-of-fit test showed the unequal distribution of confluent fibrosis location [v 5 2 = 28.26, p \ 0.0001; the last three locations (n = 1) were categorized as others]. The confluent fibrosis was most commonly seen at the boundary between the medial and anterior segments streaming of the portal blood flow, with the predominant splenic venous blood containing relatively large levels of insulin and other pancreatic hormones supplying the lateral segment [25] ; or the expected turbulent hepatopetal portal flow at the umbilical portion observed on ultrasound, resulting in reduced portal flow to the medial segment [26] , may also be implicated.
On the other hand, it is well known that when hepatic venous flow is obstructed, portal flow in the obstructed segment is markedly reduced or even reversed, resulting in the same hemodynamic conditions as in intrahepatic portal venous occlusion [11, 12] . Indeed, intrahepatic venous flow obstruction also induces marked atrophy of the obstructed liver parenchyma, as commonly observed in Budd-Chiari syndrome [27] .
Hepatic veins, unlike portal veins, are not surrounded by fibrous tissue that protects against external compression. Therefore, stricture and/or obstruction due to compression by regenerative nodules and/or fibrosis is more severe than that noted in portal veins in cirrhosis [13] . In fact, the histopathological observation revealed obliteration of small hepatic veins in cirrhosis, especially in association with regions of confluent fibrosis [28] . Therefore, we thought that the disturbances of hepatic venous drainage present in cirrhosis might markedly affect hepatic morphology, and we found selective atrophy of the MHV drainage area in patients with hepatitis-C-related cirrhosis [14] . The possible causes of the selective volume reduction seen in the MHV drainage area were considered to be as follows: the MHV is slightly shorter than the RHV, and the proximal diameter is the smallest among the three major hepatic veins in normal livers. In contrast, total volume of the MHV drainage area is the largest among LHV, MHV, and RHV drainage areas. As a result, the postsinusoidal pressure elevation seen in the MHV drainage area due to compression by regenerative nodules is expected to be larger than in the other areas [14] .
As revealed in this study, the most common site of confluent fibrosis exactly corresponded to the selective atrophic hepatic venous drainage area in cirrhosis. Therefore, confluent fibrosis may be explained as an extreme form of the selective atrophy of the MHV drainage area in cirrhosis, although this study included a variety of etiologies of cirrhosis. This is also strongly supported by the fact that confluent fibrosis was more frequently found in advanced cirrhosis. In addition, the fact that all incidences of confluent fibrosis were located in the subcapsular area, radiating from the central portion of the liver to the hepatic periphery [4, 5] , is also well explained by the larger resistance of hepatic venous drainage due to the relatively longer distance.
Although fibrosis is a common change in cirrhosis, its histological pattern varies depending on cirrhosis etiology [3] . For example, fibrous septa bridging portal triads and central veins are often seen in viral-infection-related cirrhosis. On the other hand, perivenular and perisinusoidal fibrosis is commonly seen in alcoholic cirrhosis, and cholestasis-induced liver injury shows biliary interface hepatitis, including fibroplasia in the portal area [29] . Furthermore, so-call regenerative nodules in cirrhosis that are carved by progressive hepatic fibrous bands [2] are classified as macro-, micro-, and mixed-nodular cirrhosis and also tends to depend on cirrhosis etiology [30] . However, as cirrhosis progresses, the characteristic histologic features of various etiologies may be lost, and the features of specific types of cirrhosis may be indistinguishable from cirrhosis due to other causes [2] . Thus, not only differences between a variety of etiologies but also blood flow disorders may strongly influence confluent fibrosis. In addition, a histopathological study of segmental liver atrophy suggests that the lesion was strongly associated with vascular injury [31] .
Characteristic imaging findings of fibrosis depending on cirrhosis etiology are also seen; for example, AIH shows mostly extensive reticular and/or confluent fibrosis [32] , PBC frequently shows a lace-like fibrotic pattern [33] , and alcoholic cirrhosis occasionally shows confluent fibrosis [4] , also demonstrated in this study. The distinct amount of histological fibrosis promoted by metabolic production of alcohol in alcoholic cirrhosis [34] may have some relation to the difference in the appearance of fibrosis. Therefore, the amount of fibrosis depending on specific etiologies may have a substantial influence on confluent fibrosis.
Our study had several limitations. First, the diagnosis of cirrhosis was established with pathology in only two thirds of patients. Second, the number of confluent fibrosis findings was small, and diagnosis of confluent fibrosis was established by imaging findings except in the four patients who underwent liver transplantation or partial hepatectomy. Third, actual hemodynamic evaluations of the portal and hepatic veins were not performed, although the observed changes in portal and hepatic vein hemodynamics in established confluent fibrosis is the ''result'' of confluent fibrosis and not the cause of morphologic changes. Fourth, in some patients with cirrhosis classified as Child-Pugh class C, there was some difficulty in identifying hepatic vessels because of low contrast between the liver parenchyma and hepatic vessels. Window level and width were adequately adjusted to detect fine vessels.
Conclusion
Confluent fibrosis associated with liver cirrhosis was most commonly located in the MHV drainage area.
